Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:EC 1.14.13.39 (nitric oxide synthase) inhibitor
go back to main search page
Accession:CHEBI:61908 term browser browse the term
Definition:An EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of nitric oxide synthase (EC 1.14.13.39).
Synonyms:related_synonym: EC 1.14.13.39 inhibitor;   EC 1.14.13.39 inhibitors;   NADPH-diaphorase inhibitor;   NADPH-diaphorase inhibitors;   NO synthase inhibitor;   NO synthase inhibitors;   endothelium-derived relaxation factor-forming enzyme inhibitor;   endothelium-derived relaxation factor-forming enzyme inhibitors;   endothelium-derived relaxing factor synthase inhibitor;   endothelium-derived relaxing factor synthase inhibitors;   nitric oxide synthase (EC 1.14.13.39) inhibitors;   nitric oxide synthase inhibitor;   nitric oxide synthase inhibitors;   nitric oxide synthetase inhibitor;   nitric-oxide synthetase inhibitors
 xref: Wikipedia:Nitric_oxide_synthase


show annotations for term's descendants           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19801
    role 19747
      biological role 19746
        biochemical role 19251
          enzyme inhibitor 18173
            EC 1.* (oxidoreductase) inhibitor 16530
              EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor 14228
                EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor 6407
                  EC 1.14.13.39 (nitric oxide synthase) inhibitor 4844
                    (-)-demethoxylpinoresinol 0
                    (2R*,3R*)-2,3-dihydro-7-hydroxy-2,3-dimethyl-2-[4,8-dimethyl-3(E)-7-nonadien-6-onyl]furo[3,2-c]coumarin 0
                    (2S*,3R*)-2,3-dihydro-7-hydroxy-2,3-dimethyl-2-[4,8-dimethyl-3(E),7-nonadien-6-onyl]-furo[3,2-c]coumarin 0
                    (2S*,3R*)-2,3-dihydro-7-methoxy-2,3-dimethyl-2-[4-methyl-5-(4-methyl-2-furyl)-3(E)-pentenyl]-furo[3,2-c]coumarin 0
                    (RS)-mallotophilippen E 0
                    1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone 0
                    1-O-acetyl-4R,6S-britannilactone 0
                    3-O-methyl-isosecotanapartholide 0
                    4-hydroxycinnamaldehyde 0
                    5-hydroxyzerumbone 0
                    6-propyl-2-thiouracil 4780
                    L-citrulline + 0
                    L-glutamine + 3
                    N(6)-acetimidoyl-L-lysine dihydrochloride 0
                    N(gamma)-nitro-L-arginine methyl ester 13
                    N(gamma)-nitro-L-arginine methyl ester hydrochloride 0
                    N(omega),N'(omega)-dimethyl-L-arginine + 0
                    N(omega),N(omega)-dimethyl-L-arginine + 0
                    N-[3-(aminomethyl)benzyl]acetamidine 17
                    S-methyl-L-thiocitrulline 3
                    ainsliadimer A 0
                    aminoguanidine + 69
                    bis(7)-tacrine 0
                    dihydroxanthohumol 0
                    formamidine + 6
                    fukanefuromarin A 0
                    fukanefuromarin B 0
                    fukanefuromarin C 0
                    fukanefuromarin D 0
                    fukanefuromarin E 0
                    fukanefuromarin F 0
                    fukanefuromarin G 0
                    fukanemarin A 0
                    fukanemarin B 0
                    futokadsurin A 0
                    futokadsurin B 0
                    futokadsurin C 0
                    indicanone 0
                    isosecotanapartholide 0
                    mallotophilippen A 0
                    mallotophilippen B 0
                    mallotophilippen C 0
                    mallotophilippen D 0
                    methyl propenyl ketone + 0
                    methylguanidine + 0
                    myricitrin + 27
                    nitroflurbiprofen 7
                    oroxylin A + 38
                    oroxylin A(1-) 0
                    oxygenated xanthohumol 0
                    paraminabeolide A 0
                    paraminabeolide B 0
                    paraminabeolide C 0
                    paraminabeolide D 0
                    phoyunbene A 0
                    phoyunbene B 0
                    phoyunbene C 0
                    phoyunbene D 0
                    thienodolin 0
                    triptoquinone A 0
                    xanthohumol B 0
                    xanthohumol D 0
                    zaluzanin C 0
                    zerumboneoxide 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.